Displaying drugs 1876 - 1900 of 2780 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Lesinurad | 404.28 C17H14BrN3O2S |  | A uric acid 1 transporter inhibitor typically used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout in patients with inadequate control of uric acid levels with xanthine oxidase inhibitor monotherapy. | Preparations Increasing Uric Acid Excretion |
| Ozanimod | 404.47 C23H24N4O3 |  | A sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). | Selective Immunosuppressants / Sphingosine-1-phosphate (S1P) receptor modulators |
| Sulfinpyrazone | 404.482 C23H20N2O3S |  | A platelet inhibitory and uricosuric agent used to inhibit thrombotic and embolic processes and to manage the chronic phases of gout . | Preparations Increasing Uric Acid Excretion |
| Sulfoxone | 404.482 C14H16N2O6S3 |  | For the treatment of leprosy and dermatitis herpetiformis | Drugs for Treatment of Lepra |
| Flunarizine | 404.4948 C26H26F2N2 |  | A selective calcium-entry blocker used as migraine prophylaxis in patients with severe and frequent episodes who have not responded adequately to more common treatments. | Antivertigo Preparations |
| Hydrocortisone acetate | 404.4966 C23H32O6 |  | A corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses and ulcerative colitis. | Aerosols / Anti-Inflammatory Agents / Corticosteroids |
| Lovastatin | 404.5396 C24H36O5 |  | An HMG-CoA reductase inhibitor used to lower LDL cholesterol and reduce the risk of cardiovascular disease and associated conditions, including myocardial infarction and stroke. | Anticholesteremic Agents / Drugs causing inadvertant photosensitivity / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Eliglustat | 404.551 C23H36N2O4 |  | A glucosylceramide synthase used to treat type 1 Gaucher disease in patients who are CYP2D6 extensive, intermediate, or poor metabolizers. | Various Alimentary Tract and Metabolism Products |
| Thimerosal | 404.81 C9H9HgNaO2S |  | Used as preservative in some cosmetics, topical pharmaceuticals, and biological drug products, which includes vaccines [L1671, L1672, L1673]. | Mercurial Products |
| Cabotegravir | 405.358 C19H17F2N3O5 |  | An HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection. | HIV Integrase Inhibitors / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor |
| Cephaloglycin | 405.425 C18H19N3O6S |  | For treatment of severe infections caused by susceptible bacteria. | Anti-Bacterial Agents |
| Nebivolol | 405.435 C22H25F2NO4 |  | A beta blocking agent used to treat hypertension and aid in the management of heart failure. | Antihypertensive Agents / Beta blocking agents and calcium channel blockers / Beta Blocking Agents, Selective / Beta Blocking Agents, Selective, and Thiazides |
| Lorpiprazole | 405.469 C21H26F3N5 |  | In 2016, lorpiprazole was classified in the "Chemical structure-related drug-like criteria of global approved drugs" as an antipsychotic and anxiolytic. An antipsychotic is a medication used to treat a state... | Antidepressive Agents / Central Nervous System Depressants / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Serotonin 5-HT2 Receptor Antagonists / Serotonin 5-HT2A Receptor Antagonists / Serotonin 5-HT2C Receptor Antagonists / Serotonin Agents / Serotonin Modulators / Serotonin Receptor Antagonists |
| Lisinopril | 405.4879 C21H31N3O5 |  | An ACE inhibitor used to treat hypertension, heart failure, and acute myocardial infarction. | ACE Inhibitors and Calcium Channel Blockers / ACE Inhibitors and Diuretics |
| Toremifene | 405.96 C26H28ClNO |  | A first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. | Anti-Estrogens |
| Clomifene | 405.96 C26H28ClNO |  | A medication used to induce ovulation. | Ovulation Stimulants, Synthetic |
| Ferrous ascorbate | 406.077 C12H14FeO12 |  | A medication used to treat iron-deficiency anemia. | Iron Bivalent, Oral Preparations |
| Floctafenine | 406.3552 C20H17F3N2O4 |  | An anti-inflammatory analgesic used to manage mild to moderate acute pain. | Agents that produce hypertension |
| Lorlatinib | 406.421 C21H19FN6O2 |  | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Carvedilol | 406.4742 C24H26N2O4 |  | A non selective beta-adrenergic antagonist used to treat mild to severe chronic heart failure, hypertension, and left ventricular dysfunction following myocardial infarction in clinically stable patients. | Alpha and Beta Blocking Agents |
| Lincomycin | 406.54 C18H34N2O6S |  | An antibiotic indicated only for the treatment of serious infections and is typically reserved for use in cases of penicillin allergy or where penicillin is inappropriate. | Lincosamides |
| Nandrolone phenpropionate | 406.5571 C27H34O3 |  | For the treatment of refractory deficient red cell production anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner's syndrome. It is also indicated in the... | Anabolic Agents / Androgens |
| Calcium undecylenate | 406.62 C22H38CaO4 |  | Not Annotated | Not Annotated |
| Hexachlorophene | 406.904 C13H6Cl6O2 |  | A chlorinated bisphenol antiseptic used as a surgical scrub and skin cleanser. | Phenol and Derivatives |
| Sitagliptin | 407.3136 C16H15F6N5O |  | An oral dipeptidyl peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus. | DPP-IV Inhibitors / Incretins / Triazoles |
Displaying drugs 1876 - 1900 of 2780 in total